We are live on
!
Find out more
Anavex Life Sciences
AVXL
AVXL
127 hedge funds and large institutions have $495M invested in Anavex Life Sciences in 2021 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 43 increasing their positions, 26 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
112% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 17
82% more capital invested
Capital invested by funds: $272M → $495M (+$223M)
65% more repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 26
18% more funds holding
Funds holding: 108 → 127 (+19)
3.63% more ownership
Funds ownership: 26.23% → 29.86% (+3.6%)
0% more call options, than puts
Call options by funds: $34.9M | Put options by funds: $34.8M
Holders
127
Holders Change
+19
Holders Change %
+17.59%
% of All Funds
2.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
36
Increased
43
Reduced
26
Closed
17
Calls
$34.9M
Puts
$34.8M
Net Calls
+$173K
Net Calls Change
-$3.8M
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
+$19.6M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$9.71M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.77M |
| 4 |
Morgan Stanley
New York
|
+$2.76M |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
+$2.73M |
